BA
TMO icon

Ballew Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Ballew Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-167
Closed -$38K – 404
2018
Q3 		$38K Hold
167
– – 0.03% 184
2018
Q2 		$35K Hold
167
– – 0.04% 187
2018
Q1 		$34K Buy
+167
New +$35.1K 0.03% 194

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ballew Advisors's TMO Position: Q4 2018 in Review

Ballew Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2018, closing a stake of 167 shares — an estimated $38K sold.

Ballew Advisors first reported a position in TMO in Q1 2018 and held it in 3 quarters. The position peaked at $38K in Q3 2018. 1,457 funds tracked by Wall St. Rank hold TMO as of Q4 2018.

  • Ballew Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2018 after selling out during the quarter.
  • Ballew Advisors sold 167 Thermo Fisher Scientific shares in Q4 2018, an estimated $38K.
  • Ballew Advisors first reported a position in Thermo Fisher Scientific in Q1 2018 and held it in 3 quarters.
  • Ballew Advisors's Thermo Fisher Scientific position peaked at $38K in Q3 2018.
  • 1,457 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2018.

Based on Ballew Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.